Pamprin Max Menstrual Pain Relief

Product NDC
41167-3006
11-digit product format
411673006
Labeler code
41167
Product ID
41167-3006_14eab422-6e81-4f2e-9272-81f8f170c154
Type
HUMAN OTC DRUG
Nonproprietary name
Acetaminophen and Aspirin and Caffeine
Dosage form
TABLET
Route
ORAL
Labeler
Chattem, Inc.
Application
part343
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2006-02-01
Marketing end
0000-00-00
Substance
ACETAMINOPHEN; ASPIRIN; CAFFEINE
Active strength
250 mg/1; mg/1; mg/1
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct41167-3006DDiscontinued by firm2026-10-12
excluded packagepackage41167-300641167-3006-5DDiscontinued by firm2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage41167-3006-5d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage41167-3006-5f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage41167-3006-52ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage41167-3006-5a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage41167-3006-5cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage41167-3006-5cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage41167-3006-5302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage41167-3006-5ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage41167-3006-50efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage41167-3006-5ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage41167-3006-5367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage41167-3006-5557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
ASPIRINACTIVE INGREDIENTR16CO5Y76EPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
CAFFEINEACTIVE INGREDIENT3G6A5W338EPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
ACETAMINOPHENACTIVE MOIETY362O9ITL9DPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
ASPIRINACTIVE MOIETYR16CO5Y76EPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
CAFFEINEACTIVE MOIETY3G6A5W338EPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
D&C RED NO. 27INACTIVE INGREDIENT2LRS185U6KPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOAPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2DPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
MEDIUM-CHAIN TRIGLYCERIDESINACTIVE INGREDIENTC9H2L21V7UPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
POLYDEXTROSEINACTIVE INGREDIENTVH2XOU12IEPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4PAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
TALCINACTIVE INGREDIENT7SEV7J4R1UPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPPAMPRIN MAX MENSTRUAL PAIN RELIEF (ACETAMINOPHEN AND ASPIRIN AND CAFFEINE) TABLET [CHATTEM, INC.]4